Angiogenesis Modulators & Therapeutics |Technology, cardiology, ophthalmology
Aarkstore Enterprise (India), July 12th , 2013:
This report on Angiogenesis Modulators & Therapeutics studies the impact of Inhibitors and Stimulators on various diseases. The study focuses on major angiogenesis inhibitors and their role in diseases such as cancer, cardiology, ophthalmology, and other angiogenesis based diseases including endometriosis and inflammatory diseases. The emphasis is also given on major angiogenesis stimulators and their role in diseases such as cardiovascular disorders including ischemia, congestive heart failure, coronary artery disease, myocardial infarction and peripheral vascular disease and chronic wound care. The study provides global market analysis for angiogenesis therapeutic products by the above angiogenesis modulators and also by the disease areas such as cancer, cardiovascular disorders and other angiogenesis based diseases. Compilation of Worldwide Patents and Research related to Angiogenesis is also provided. The study includes estimations and predictions for the total global angiogenesis therapeutic products market. Estimations and predictions are also graphically illustrated by geographic regions encompassing the North America, Europe, Asia-Pacific and Rest of World.
Table of Contents :
1. SCOPE AND METHODOLOGY
2. REPORT SYNOPSIS
Angiogenesis Therapeutic Products
Exhibit 1. Segmentation of Global Angiogenesis Modulators & Therapeutics Market by Angiogenesis Modulators and Therapeutic Area
Angiogenesis – Therapeutic Areas
2.2 Angiogenesis Modulators & Therapeutics – Global Market Analysis
Exhibit 2. Angiogenesis Modulators & Therapeutics – Global Market Estimations & Predictions (2005 -2015) in US$ Million (Graphical Representation Included)
To Read The Complete Report with TOC Kindly Visit:
Email: email@example.com | firstname.lastname@example.org
24/7 Online Support: (+91) 8149852585
ListFree.org: Embedded data.